{"id":695592,"date":"2026-03-11T11:26:36","date_gmt":"2026-03-11T15:26:36","guid":{"rendered":"https:\/\/www.rochester.edu\/newscenter\/?p=695592"},"modified":"2026-07-05T12:07:32","modified_gmt":"2026-07-05T16:07:32","slug":"mindtrace-brain-mapping-technology-tumor-surgery-695592","status":"publish","type":"post","link":"https:\/\/www.rochester.edu\/newscenter\/mindtrace-brain-mapping-technology-tumor-surgery-695592\/","title":{"rendered":"New brain-mapping technology enhances tumor surgery at Ä¢¹½´«Ã½"},"content":{"rendered":"
When brain surgeons at the Ä¢¹½´«Ã½ Medical Center<\/a> plan a tumor operation, they\u2019re increasingly guided by more than scans and experience alone. A next-generation platform called MindTrace\u2014developed from decades of neuroscience and neurosurgical research rooted at the Ä¢¹½´«Ã½<\/a>\u2014helps surgical teams predict how different surgical decisions could affect a patient\u2019s speech, movement, and other vital functions before tissue is removed.<\/p>\n The technology grew out of the University\u2019s Program for Translational Brain Mapping<\/a>, founded by cognitive neuroscientist Brad Mahon and neurosurgeon Webster Pilcher<\/a>. Working alongside collaborators, including Simon Business School<\/a> alumnus Max Sims, now the CEO of MindTrace, the team developed early prototypes that integrated neuroimaging and behavioral data into a single, practical tool for the operating room. The system is now deployed at six major medical centers nationwide, with the Medical Center among the first to implement it clinically.<\/p>\n By combining functional MRI, brain stimulation mapping, and neuropsychological testing, surgeons can visualize and replay brain-mapping data in real time, helping clinicians optimize their care decisions and patients better understand their surgeries.<\/p>\n